Download PDF
1 / Pages

Other users also viewed these articles

Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial Alvar Agusti; José Luis Lopez-Campos; Marc Miravitlles; Juan Jose Soler-Cataluña; Jose Maria Marin; Borja G. Cosio; Bernardino Alcázar-Navarrete; Jose Maria Echave-Sustaeta; Ciro Casanova; German Peces-Barba; Juan Pablo de-Torres; Alberto Fernandez-Villar; Julio Ancochea; Felipe Villar-Alvarez; Miguel Roman-Rodriguez; Jesus Molina; Juan Luis Garcia-Rivero; Cruz Gonzalez; Patricia Sobradillo; Rosa Faner; Carolina Peña; Raj Sharma; José Luis Izquierdo; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:417-22
Effect of carbocysteine on exacerbations and lung function in patients with mild-to-moderate chronic obstructive pulmonary disease: a multicentre, double-blind, randomised, placebo-controlled trial Yumin Zhou; Fan Wu; Haiqing Li; Zhishan Deng; Li Lin; Hong Huang; Haiyan Zhao; Yiran Wang; Lingwei Wang; Qijian Chen; Shan Cai; Zhiyi He; Yinghua Ying; Peiyu Huang; Heshen Tian; Jieqi Peng; Shan Xiao; Xiang Wen; Huajing Yang; Youlan Zhen; Zihui Wang; Ningning Zhao; Lifei Lu; Jianwu Xu; Qiuyue Wang; Pixin Ran;
10.1016/j.arbres.2025.01.004
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses Alberto Papi; Franco Alfano; Tommaso Bigoni; Lorenzo Mancini; Amal Mawass; Federico Baraldi; Cristina Aljama; Marco Contoli; Marc Miravitlles;
Arch Bronconeumol. 2024;60:269-78